Clinical Trial Update: Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a gene therapy targeting Leber's Hereditary Optic Neuropathy (LHON) at Phase 2/Phase 3; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Snippet

Sponsor: Wuhan Neurophth Biotechnology Limited Company | Conditions: Leber's Hereditary Optic Neuropathy (LHON) | Phase 2, Phase 3 | Status: RECRUITING